Dose-response of ritonavir on hepatic CYP3A activity and elvitegravir oral exposure.
Mathias AA; West S; Hui J; Kearney BP; Clinical Pharmacology And Therapeutics, 2009, vol. 85, issue 1, p 64, ISSN 15326535. ISBN 15326535.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef